Can emicizumab keep hemophilia joints healthy? new study aims to find out
NCT ID NCT07420348
First seen Feb 24, 2026 · Last updated May 24, 2026 · Updated 12 times
Summary
This study watches about 70 people with hemophilia A who are already taking emicizumab to prevent bleeding. Researchers will use ultrasound to check if their elbows, knees, and ankles develop any early joint damage over two years. The goal is to learn how well the treatment protects joints that are still healthy at the start.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universidad de Oviedo
Oviedo, Principality of Asturias, 33006, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.